Despite the high cardiovascular risk associated with chronic kidney disease, a recent systematic review confirmed that patients with kidney disease remain underrepresented in cardiovascular trials. Two ongoing trials are assessing the risk:benefit of aggressive evaluation and intervention for ischemic heart disease in patients with advanced chronic kidney disease.
View details for DOI 10.1016/j.kint.2016.03.012
View details for Web of Science ID 000375693100002
View details for PubMedID 27181770